Announcements

Home > Investor Relations >Announcements
Back List
Announcement of Key Resolutions of CCSB 2019 Annual General Shareholders' Meeting date : 2019/05/31

 

Provided by: Chunghwa Chemical Synthesis & Biotech Co., Ltd.

 

SEQ_NO

1

Date of announcement

2019/05/31

Time of announcement

20:12:19

Spokesman:

Chuan-Wen Chen

Title of Spokesman:

Vice President

Subject

Announcement of Key Resolutions of CCSB 2019 Annual General Shareholders' Meeting.

To which item it meets

paragraph 18

Date of events

2019/05/31

Statement

1. Date of the shareholders' meeting: 2019/05/31

2. Important resolutions (1) profit distribution/deficit compensation:

Ratification of the distribution of 2018 earnings. Cash dividend to shareholders totals NT$93,072,000. (The cash dividend is NT$1.2 per share)

3. Important resolutions (2) amendments of the corporate charter: None

4. Important resolutions (3) business report and financial statements:

Ratification of the business report and financial statements of 2018.

5. Important resolutions (4) elections of board of directors and supervisors:

To elect Directors (including independent directors)

Newly elected Directors

Representative of CHINA CHEMICAL & PHARMACEUTICAL CO., LTD./ WANG, HSUN-SHENG

Representative of WANG MING-NING MEMORIAL FOUNDATION./ WANG, HSUN -HUI

Representative of WANG MING-NING MEMORIAL FOUNDATION./ HUANG ,JONG-SHINN

Representative of CHINA CHEMICAL & PHARMACEUTICAL CO., LTD./ SUN, YIN-NAN

Newly elected Independent Directors

WANG ,KUO-CHIANG

TSAI ,CHUNG-HSIEN

CHANG ,CHIH-HSIEN

6. Important resolutions (5) other proposals:

a. Approval to amend partial Articles of the Procedures for Acquisition or Disposal of Assets.

b. Approval to amend partial Articles of the Procedures for Financial Derivatives Transactions.

C. Approval to amend partial Articles of the Procedures for Loaning Funds to Others.

d. Approval to amend partial Articles of the Procedures for Endorsement & Guarantee.

e.Approval to release non-compete restrictions on newly elected directors and authorized representatives.

7. Any other matters that need to be specified: None